Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmascience Inc.

www.pharmascience.com

Latest From Pharmascience Inc.

Pharmascience Win In Canada Clarifies Damages Rules

Canada’s Federal Court of Appeal has dismissed an attempt by Pfizer to limit damages owed to Pharmascience as part of litigation over pregabalin. The court rejected Pfizer’s argument that the generics firm was not entitled to certain damages for lost sales that Pfizer said could have been blocked by the originator hypothetically seeking to enforce a patent protecting the Lyrica brand.

Legal Issues Intellectual Property

Ranitidine Distribution Stops In Canada As Regulators Assess Contamination Threat

Health Canada asks ranitidine H2 blocker firms to halt sales until it gathers more information on NDMA contamination, which may form due to the drug’s instability. At least one marketer, Sandoz, also is recalling its ranitidine products in both Canada and US.

Europe Canada

Redx Pharma PLC

Redx Pharma PLC and its subsidiaries are focused on developing proprietary, small-molecule therapeutics to address areas of high unmet medical need principally in cancer, infection and autoimmune disease.

BioPharmaceutical

Industry Roundup: GMPs, DXM, Pharmascience, Rock Creek

Herbal firm crosses GMP, claims lines; Kentucky makes 8 to age-restrict DXM sales; Pharmascience expands with Quebec support; Rock Creek closes share offerings; and more news in brief.

Consumer Mexico
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Pharmascience Inc.
  • Senior Management
  • David Goodman, CEO
    Larry MacGirr, COO
  • Contact Info
  • Pharmascience Inc.
    Phone: (514) 340-9800
    6111 Royalmount Ave.
    Ste. 100
    Montreal, H4P 2T4
    Canada
UsernamePublicRestriction

Register